OSE Immunotherapeutics (OSE)
EU
年末 2023年12月31日 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
総資産 | 89.55M | 77.35M | 76.9M | 88.93M | 96.97M | 101.88M | 91.78M | 82.05M |
流動資産合計 | 36.54M | 23.99M | 23.02M | 33.06M | 39.83M | 44.21M | 37.2M | 30.48M |
現金および同等物 | 14.89M | 9.65M | 9.57M | 25.84M | 29.37M | 33.58M | 25.62M | 18.67M |
非流動資産合計 | 64.53M | 55.45M | 61.75M | 58.54M | 61.36M | 47.89M | 32.66M | 22.98M |
負債合計 | 25.02M | 21.91M | 15.15M | 30.4M | 35.61M | 53.99M | 59.12M | 59.08M |
流動負債合計 | 18.66M | 14.5M | 9.08M | 14.33M | 14.13M | 16.76M | 16.27M | 18.8M |
非流動負債合計 | 7.54M | 11.7M | 9.91M | 26.69M | 40.35M | 71.99M | 83.67M | 78.82M |
総資本 | 64.53M | 55.45M | 61.75M | 58.54M | 61.36M | 47.89M | 32.66M | 22.98M |
普通株 | 2.86M | 2.9M | 2.96M | 3M | 3.6M | 3.71M | 3.71M | 4.33M |
留保所得 | -20.67M | -10.5M | 0 | -4.65M | -16.56M | -16.85M | -17.76M | -23.01M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約